110 related articles for article (PubMed ID: 9461083)
1. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.
Heeringa P; Brouwer E; Tervaert JW; Weening JJ; Kallenberg CG
Kidney Int; 1998 Feb; 53(2):253-63. PubMed ID: 9461083
[No Abstract] [Full Text] [Related]
2. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Kettritz R
J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?
Locke IC; Cambridge G
Br J Biomed Sci; 1996 Dec; 53(4):302-16. PubMed ID: 9069109
[TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil and antineutrophil cytoplasmic antibody associated vasculitis: the detective finds a clue.
Pillinger MH; Staud R
Semin Arthritis Rheum; 2006 Aug; 36(1):1-3. PubMed ID: 16887462
[No Abstract] [Full Text] [Related]
5. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis.
Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1221-3. PubMed ID: 16624927
[No Abstract] [Full Text] [Related]
6. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
Pankhurst T; Savage CO
Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Tervaert JW; Heeringa P
Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
[TBL] [Abstract][Full Text] [Related]
8. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jennette JC; Falk RJ
Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
[TBL] [Abstract][Full Text] [Related]
9. Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis.
Walsh M; Tonelli M; Jayne D; Manns B
J Nephrol; 2007; 20(2):119-29. PubMed ID: 17514615
[No Abstract] [Full Text] [Related]
10. Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis.
Tervaert JW; Damoiseaux J; Boomsma MM; Stegeman CA
Arthritis Rheum; 2002 Mar; 46(3):849-50. PubMed ID: 11920433
[No Abstract] [Full Text] [Related]
11. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.
de Lind van Wijngaarden RA; van Rijn L; Hagen EC; Watts RA; Gregorini G; Tervaert JW; Mahr AD; Niles JL; de Heer E; Bruijn JA; Bajema IM
Clin J Am Soc Nephrol; 2008 Jan; 3(1):237-52. PubMed ID: 18077783
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
Zhao MH; Chen M; Gao Y; Wang HY
Kidney Int; 2006 Apr; 69(8):1477-81. PubMed ID: 16572106
[No Abstract] [Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies: are they pathogenic?
Specks U
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S7-12. PubMed ID: 15675127
[No Abstract] [Full Text] [Related]
14. Apoptosis: the central actor in the three hits that trigger anti-neutrophil cytoplasmic antibody-related systemic vasculitis.
Esnault VL
Nephrol Dial Transplant; 2002 Oct; 17(10):1725-8. PubMed ID: 12270975
[No Abstract] [Full Text] [Related]
15. Anti-neutrophil cytoplasmic antibody (ANCA)-associated microscopic polyangiitis following a suppurative wound infection.
Chan B; d'Intini V; Savige J
Nephrol Dial Transplant; 2006 Oct; 21(10):2993-4. PubMed ID: 16887851
[No Abstract] [Full Text] [Related]
16. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Flossmann O; Jones RB; Jayne DR; Luqmani RA
Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasm-associated glomerulonephritis.
Morgan MD; Harper L; Williams J; Savage C
J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
[TBL] [Abstract][Full Text] [Related]
18. Large vessel compromise in antineutrophil cytoplasmic antibody-associated systemic vasculitis: comment on the article by Booth et al.
Chirinos JA; Tamariz LJ; Lichtstein DL
Arthritis Rheum; 2004 Oct; 50(10):3398-9; author reply 3399-400. PubMed ID: 15476214
[No Abstract] [Full Text] [Related]
19. Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies.
Lamprecht P; Gross WL
Trends Immunol; 2008 Dec; 29(12):587-8. PubMed ID: 18951843
[No Abstract] [Full Text] [Related]
20. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
Feldmann M; Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
